VIM and breast cancer: To determine if the epithelial characteristics of breast cancer cells exhibited transitions during clinical treatment with tamoxifen, the expression of EMT marker proteins (E-cadherin, vimentin and fibronectin) was investigated in these 53 GPER+ MTs and paired PTs.